Table 2 Correlations of serum levels for BLyS and APRIL to lupus activity parameters, pathological scores, and renal and systemic involvement at baseline.
From: APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
| Â | Â | BLyS | APRIL |
|---|---|---|---|
Renal parameters | Â | Â | Â |
R_SLEDAI | Â | -0.17 | 0.22 |
Serum creatinine | mg/dl | 0.06 | 0.06 |
Erythrocyturia | cells/high power field | -0.13 | 0.06 |
Urine protein | g/day | -0.05 | 0.44** |
Activity score | Â | -0.11 | 0.34* |
Chronicity score | Â | 0.25 | 0.20 |
Lupus parameters | Â | Â | Â |
ANA titer | Â | -0.20 | 0.02 |
Anti-dsDNA titer | Â | -0.28 | 0.23 |
Complement factor 3 | mg/dl | 0.46** | -0.44** |
Total leukocyte count | cells/mm3 | -0.49*** | 0.26 |
Polymorph | cells/mm3 | -0.40** | 0.18 |
Lymphocyte | cells/mm3 | -0.42*** | -0.14 |
Treatment | Â | Â | Â |
Prednisolone | mg/day | 0.46*** | 0.25 |
Mycophenolate | mg/day | 0.37** | -0.09 |